Lifecore Biomedical, Inc. reports results for the quarter ended June 30 - Earnings Summary

Lifecore Biomedical

05/08/2026 14:31

Lifecore Biomedical, Inc. LFCR.OQ reported a quarterly adjusted loss of 19 cents​​ per share for the quarter ended June 30.  The mean expectation of three analysts for the quarter was for a loss of 22 cents per share. Wall Street expected results to range from -30 cents to -17 cents per share.
Revenue was $34.17 million​; analysts expected $32.02 million. 
Lifecore Biomedical, Inc.'s reported EPS for the quarter was a loss of 19 cents​.
The company reported a quarterly loss of $7.13 million.
Lifecore Biomedical, Inc. shares had fallen by 17.1% this quarter and lost 46.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 11.8% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." 
This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.22
-0.19
Beat
Mar. 31 2026 
-0.24
-0.43
Missed